Loss of YTHDF2 Alters the Expression of m6A-Modified Myzap and Causes Adverse Cardiac Remodeling
暂无分享,去创建一个
D. Terentyev | A. S. Das | L. Dorn | Christopher J. Gilbert | Volha A. Golubeva | R. Veress | Charles P. Rabolli | F. Accornero | V. Wanasinghe | V. S. Wanasinghe | Roland Veress
[1] Kate D. Meyer,et al. Single-molecule identification of the target RNAs of different RNA binding proteins simultaneously in cells , 2022, bioRxiv.
[2] B. Peterlin,et al. A biallelic loss-of-function variant in MYZAP is associated with a recessive form of severe dilated cardiomyopathy , 2022, Cold Spring Harbor molecular case studies.
[3] Junjie Xiao,et al. Downregulation of circ-ZNF609 Promotes Heart Repair by Modulating RNA N6-Methyladenosine-Modified Yap Expression , 2022, Research.
[4] Yuan Zhang,et al. The lncRNA MIAT regulates CPT-1a mediated cardiac hypertrophy through m6A RNA methylation reading protein Ythdf2 , 2022, Cell death discovery.
[5] Liang Ma,et al. YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy , 2021, Cell & Bioscience.
[6] J. Ge,et al. Alteration of m6A RNA Methylation in Heart Failure With Preserved Ejection Fraction , 2021, Frontiers in Cardiovascular Medicine.
[7] B. Whitson,et al. Remodeling of the m6A landscape in the heart reveals few conserved post-transcriptional events underlying cardiomyocyte hypertrophy. , 2020, Journal of molecular and cellular cardiology.
[8] A. Caflisch,et al. Structural and Dynamic Insights into Redundant Function of YTHDF Proteins , 2020, J. Chem. Inf. Model..
[9] Gene W. Yeo,et al. Context-dependent functional compensation between Ythdf m6A reader proteins , 2020, Genes & development.
[10] Samie R. Jaffrey,et al. A Unified Model for the Function of YTHDF Proteins in Regulating m6A-Modified mRNA , 2020, Cell.
[11] Ok Hyun Park,et al. Molecular Mechanisms Driving mRNA Degradation by m6A Modification. , 2020, Trends in genetics : TIG.
[12] G. Hasenfuss,et al. Changes in m6A RNA methylation contribute to heart failure progression by modulating translation , 2019, European journal of heart failure.
[13] Ulrike A. Friedrich,et al. Monitoring Cell-Type–Specific Gene Expression Using Ribosome Profiling In Vivo During Cardiac Hemodynamic Stress , 2019, Circulation research.
[14] Catherine L. Worth,et al. The Translational Landscape of the Human Heart , 2019, Cell.
[15] Jing Wang,et al. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs , 2019, Nucleic Acids Res..
[16] Christoph Dieterich,et al. m6A-mRNA methylation regulates cardiac gene expression and cellular growth , 2019, Life Science Alliance.
[17] Murugesan V. S. Rajaram,et al. The lung mucosa environment in the elderly increases host susceptibility to Mycobacterium tuberculosis infection. , 2019, The Journal of infectious diseases.
[18] J. Hanna,et al. The N6-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy , 2018, Circulation.
[19] R. Hajjar,et al. FTO-Dependent N6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair , 2018, Circulation.
[20] Federica Accornero,et al. At the heart of inter- and intracellular signaling: the intercalated disc , 2018, Biophysical Reviews.
[21] I. Kehat,et al. Localization of transcripts, translation, and degradation for spatiotemporal sarcomere maintenance. , 2018, Journal of molecular and cellular cardiology.
[22] Da-Zhi Wang,et al. How cardiomyocytes sense pathophysiological stresses for cardiac remodeling , 2016, Cellular and Molecular Life Sciences.
[23] Chuan He,et al. YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA , 2017, Cell Research.
[24] Ping Wang,et al. Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. , 2016, Molecular cell.
[25] R. Lüllmann-Rauch,et al. Myozap Deficiency Promotes Adverse Cardiac Remodeling via Differential Regulation of Mitogen-activated Protein Kinase/Serum-response Factor and β-Catenin/GSK-3β Protein Signaling* , 2015, The Journal of Biological Chemistry.
[26] M. Swanson,et al. MBNL1-mediated regulation of differentiation RNAs promotes myofibroblast transformation and the fibrotic response , 2015, Nature Communications.
[27] Matthieu Schapira,et al. Structural Basis for the Discriminative Recognition of N6-Methyladenosine RNA by the Human YT521-B Homology Domain Family of Proteins* , 2015, The Journal of Biological Chemistry.
[28] Chuan He,et al. N 6 -methyladenosine Modulates Messenger RNA Translation Efficiency , 2015, Cell.
[29] B. C. Bernardo,et al. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets , 2015, Archives of Toxicology.
[30] Miao Yu,et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation , 2013, Nature chemical biology.
[31] Zhike Lu,et al. m6A-dependent regulation of messenger RNA stability , 2013, Nature.
[32] N. Frey,et al. Mice with cardiac-restricted overexpression of Myozap are sensitized to biomechanical stress and develop a protein-aggregate-associated cardiomyopathy. , 2013, Journal of molecular and cellular cardiology.
[33] Arne Klungland,et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. , 2013, Molecular cell.
[34] H. Marr,et al. Rbfox-regulated alternative splicing is critical for zebrafish cardiac and skeletal muscle functions. , 2011, Developmental biology.
[35] William E Louch,et al. Methods in cardiomyocyte isolation, culture, and gene transfer. , 2011, Journal of molecular and cellular cardiology.
[36] Chengqi Yi,et al. N6-Methyladenosine in Nuclear RNA is a Major Substrate of the Obesity-Associated FTO , 2011, Nature chemical biology.
[37] A. Wilde,et al. Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. , 2011, Journal of the American College of Cardiology.
[38] N. Norton,et al. Identification of Novel Mutations in RBM20 in Patients with Dilated Cardiomyopathy , 2010, Clinical and translational science.
[39] W. Rottbauer,et al. Myozap, a Novel Intercalated Disc Protein, Activates Serum Response Factor–Dependent Signaling and Is Required to Maintain Cardiac Function In Vivo , 2010, Circulation research.
[40] Michael Hiller,et al. The YTH Domain Is a Novel RNA Binding Domain* , 2010, The Journal of Biological Chemistry.
[41] M. Delmar. The intercalated disk as a single functional unit. , 2004, Heart rhythm.
[42] S. Stamm,et al. YTH: a new domain in nuclear proteins. , 2002, Trends in biochemical sciences.
[43] J. Molkentin,et al. The Transcription Factors GATA4 and GATA6 Regulate Cardiomyocyte Hypertrophy in Vitro and in Vivo * , 2001, The Journal of Biological Chemistry.
[44] Jeffrey Robbins,et al. A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.